Benefits of two drugs in treating type 1 diabetes compared

[Northerner]

Participants between the ages of 11 and 36 received either the two drugs or a placebo while continuing their insulin injections. The group receiving the drugs did not experience an improvement in insulin production, but some study participants whose GLP-1 and gastrin levels increased may have better preserved beta cell levels.

http://www.sciencedaily.com/releases/2014/07/140703142158.htm